DAMAN P/S enters personal RA medicine project
Danish AI health app developer DAMAN P/S has entered the €12m EU-funded Squeeze project, that aims to find stratification biomarkers for DMARDs in rheumatoid arthritis (RA).
ADVERTISEMENT
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 2153 entries already.
Entries by Thomas Gabrielczyk
Transformative innovation in drug development
The technological and pharmacological advances lead to an increase in the number of molecules for R&D that are challenging and difficult to manufacture. To improve clinical success, pharma and biotech companies are seeking innovative ways to accelerate progress and reduce scientific, economic, and delivery risks.
AI specialist Quinten Health bags €14m financing
Quinten Group’s French healthcare arm Quinten Health has closed a financing round to advance disease modeling platforms and virtual twins in real-world.
Bavarian Nordic expands vaccine contract by $234m
Bavarian Nordic A/S has expand its smallpox contract signed with the Canadian PHAC in June from $56m to $470m including $180m in contract options.
Why vaccine developers need a Charged Aerosol Detector: Reason 3
Why are so many vaccine developers choosing Thermo Scientific Charged Aerosol Detection (CAD)? Hear the third very good reasons why CAD was used for analysis of lipid nanoparticles in approved mRNA vaccines.
Genfit swallows Versantis in €105m deal
Through the acquisition of Versantis for €40m upfront and further €65m in milestones, Genfit SA has added three clinical and preclinical candidates to its liver drug portfolio.
Food specialist Standing Ovation SA raises €12m
Foodtech startup Standing Ovation SA has closed an oversubscribed €12m Series A financing round led by Astanor Ventures.
HeartBeat.bio inks partnership with Molecular Devices
HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput drug discovery screening
Mobile app recognises COVID-19 infection
Dutch researchers report they could detect a COVID-19 infection with better sensitivity than antigen tests by a mobile app that uses AI to analyse voice recordings.
Pleco Therapeutics raises €17.3m in Series A
Dutch Pleco Therapeutics BV has raised €17.3m in a Series A financing to push its lead candidate in acute myeloid leukaemia to market approval.